AMED insider trading
CIK 896262AMEDISYS INC: insider trade history from SEC Form 4 filings.
AMED insider activity at a glance
FilingIQ tracks 906 insider transactions for AMED in filings since Mar 16, 2015. The most recent transaction is dated Aug 14, 2025. They were reported by 39 insiders.
Across the full history, 13 open-market purchases
and 292 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest AMED Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Tickers with similar insider activity
Ranked next to AMED by Form 4 lines in the last 90 days, the number on each card.
Frequently asked
- How many insider trades does FilingIQ track for AMED?
- FilingIQ tracks 906 Form 4 insider transactions for AMED (AMEDISYS INC), covering filings from Mar 16, 2015 onwards. 0 of those are dated within the last 90 days.
- Are AMED insiders net buyers or net sellers?
- Across the full Form 4 history for AMED, 13 transactions (1%) were open-market purchases and 292 (32%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AMED insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
Methodology & sources
Every AMED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.